June 23, 2021—RapidPulse, Inc. announced the closing of a $15 million Series A financing that the company plans to use to advance its RapidPulse cyclic aspiration system through expanded clinical evaluation and build out its platform of proprieta…
Category: FDA
Penumbra’s Red 62 Reperfusion Catheter Cleared by FDA
June 23, 2021—Penumbra, Inc. announced FDA 510(k) clearance and commercial availability of the Red 62 reperfusion catheter, an addition to the Penumbra system for mechanical thrombectomy.
According to the company, Red 62 is designed to navigat…